Maria João Amorim and Cláudio Franco, Group Leaders at Católica Biomedical Research Centre and Associate Professors at the Católica Medical School, secured two research grants in the CaixaResearch Health Call 2022 of ”la Caixa” Foundation.
Maria João Amorim will contribute to the development of a platform that rapidly designs and produces new biopharmaceuticals to treat emerging viruses. The researchers will initially focus on influenza A and SARS-CoV-2 viruses, with the ambition to provide a versatile toolbox adaptable to new viral outbreaks. The consortium led by Cláudio M. Soares (Instituto de Tecnologia Química e Biológica António Xavier), and with contribution of Ana Salomé Veiga (Instituto de Medicina Molecular João Lobo Antunes) and José Maria Valpuesta (Consejo Superior de Investigaciones Científicas), will receive 1M€ for this research endeavour.
Cláudio Franco will receive 500.000€ to study the role of endothelial cells, which line the interior of blood vessels, in aging. His team will explore how endothelial cells communicate with organs to prevent the onset of age-related diseases and thus promote healthy aging.
“la Caixa” Foundation supports the most promising basic, clinical or translational research projects of scientific excellence with great potential value and high social impact in areas such as Neuroscience, Oncology, Cardiovascular or Infectious diseases, as well as in related enabling technologies.
The CaixaResearch Health Call 2022 has awarded a total of 23 million euros to 33 biomedical research projects, with individual budgets ranging from 0.5 to 1M €. Of the finalist projects, 13 will be led by Portuguese institutions, and three have been chosen in collaboration with the Fundação para a Ciência e a Tecnologia (FCT).
Since the beginning of the programme in 2018, ”la Caixa” granted 94.8M € to 138 biomedical research projects - 95 led by research teams based in Spain and 43 led by teams based in Portugal.
2023 Call for projects with the deadline on November 15, 2022, has just been announced.